386 related articles for article (PubMed ID: 19183436)
1. Increased PADI4 expression in blood and tissues of patients with malignant tumors.
Chang X; Han J; Pang L; Zhao Y; Yang Y; Shen Z
BMC Cancer; 2009 Jan; 9():40. PubMed ID: 19183436
[TBL] [Abstract][Full Text] [Related]
2. Expression of peptidylarginine deiminase type 4 in ovarian tumors.
Wang L; Chang X; Yuan G; Zhao Y; Wang P
Int J Biol Sci; 2010 Aug; 6(5):454-64. PubMed ID: 20827398
[TBL] [Abstract][Full Text] [Related]
3. Investigating the pathogenic role of PADI4 in oesophageal cancer.
Chang X; Hou X; Pan J; Fang K; Wang L; Han J
Int J Biol Sci; 2011; 7(6):769-81. PubMed ID: 21698003
[TBL] [Abstract][Full Text] [Related]
4. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis.
Chang X; Yamada R; Suzuki A; Sawada T; Yoshino S; Tokuhiro S; Yamamoto K
Rheumatology (Oxford); 2005 Jan; 44(1):40-50. PubMed ID: 15466895
[TBL] [Abstract][Full Text] [Related]
5. PADI4 stimulates esophageal squamous cell carcinoma tumor growth and up-regulates CA9 expression.
Liu C; Tang J; Li C; Pu G; Yang D; Chang X
Mol Carcinog; 2019 Jan; 58(1):66-75. PubMed ID: 30242913
[TBL] [Abstract][Full Text] [Related]
6. Regulation of protein Citrullination through p53/PADI4 network in DNA damage response.
Tanikawa C; Ueda K; Nakagawa H; Yoshida N; Nakamura Y; Matsuda K
Cancer Res; 2009 Nov; 69(22):8761-9. PubMed ID: 19843866
[TBL] [Abstract][Full Text] [Related]
7. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.
Suzuki A; Kochi Y; Shoda H; Seri Y; Fujio K; Sawada T; Yamada R; Yamamoto K
BMC Musculoskelet Disord; 2016 May; 17():205. PubMed ID: 27150598
[TBL] [Abstract][Full Text] [Related]
8. The role of peptidylarginine deiminase 4 in ovarian cancer cell tumorigenesis and invasion.
Cui YY; Yan L; Zhou J; Zhao S; Zheng YB; Sun BH; Lv HT; Rong FN; Chang XT
Tumour Biol; 2016 Apr; 37(4):5375-83. PubMed ID: 26563365
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and biophysical characterization of PADI4 supports its involvement in cancer.
Neira JL; Araujo-Abad S; Cámara-Artigas A; Rizzuti B; Abian O; Giudici AM; Velazquez-Campoy A; de Juan Romero C
Arch Biochem Biophys; 2022 Mar; 717():109125. PubMed ID: 35081374
[TBL] [Abstract][Full Text] [Related]
10. The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis.
Chang X; Yamada R; Sawada T; Suzuki A; Kochi Y; Yamamoto K
Rheumatology (Oxford); 2005 Mar; 44(3):293-8. PubMed ID: 15561738
[TBL] [Abstract][Full Text] [Related]
11. Anti-PADI4 antibody suppresses breast cancer by repressing the citrullinated fibronectin in the tumor microenvironment.
Wang Y; Liu C; Zhang N; Song X; Song Y; Cai D; Fang K; Chang X
Biomed Pharmacother; 2022 Sep; 153():113289. PubMed ID: 35772376
[TBL] [Abstract][Full Text] [Related]
12. Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis.
Takizawa Y; Sawada T; Suzuki A; Yamada R; Inoue T; Yamamoto K
Scand J Rheumatol; 2005; 34(3):212-5. PubMed ID: 16134727
[TBL] [Abstract][Full Text] [Related]
13. The expression of PADI4 in synovium of rheumatoid arthritis.
Chang X; Zhao Y; Sun S; Zhang Y; Zhu Y
Rheumatol Int; 2009 Oct; 29(12):1411-6. PubMed ID: 19199100
[TBL] [Abstract][Full Text] [Related]
14. PADI4 Epigenetically Suppresses p21 Transcription and Inhibits Cell Apoptosis in Fibroblast-like Synoviocytes from Rheumatoid Arthritis Patients.
Fan L; Zong M; Gong R; He D; Li N; Sun LS; Ye Q; Yu S
Int J Biol Sci; 2017; 13(3):358-366. PubMed ID: 28367100
[TBL] [Abstract][Full Text] [Related]
15. Histone citrullination by PADI4 is required for HIF-dependent transcriptional responses to hypoxia and tumor vascularization.
Wang Y; Lyu Y; Tu K; Xu Q; Yang Y; Salman S; Le N; Lu H; Chen C; Zhu Y; Wang R; Liu Q; Semenza GL
Sci Adv; 2021 Aug; 7(35):. PubMed ID: 34452909
[TBL] [Abstract][Full Text] [Related]
16. PADI4 has genetic susceptibility to gastric carcinoma and upregulates CXCR2, KRT14 and TNF-α expression levels.
Zheng Y; Zhao G; Xu B; Liu C; Li C; Zhang X; Chang X
Oncotarget; 2016 Sep; 7(38):62159-62176. PubMed ID: 27556695
[TBL] [Abstract][Full Text] [Related]
17. Citrullination of DNMT3A by PADI4 regulates its stability and controls DNA methylation.
Deplus R; Denis H; Putmans P; Calonne E; Fourrez M; Yamamoto K; Suzuki A; Fuks F
Nucleic Acids Res; 2014 Jul; 42(13):8285-96. PubMed ID: 24957603
[TBL] [Abstract][Full Text] [Related]
18. PAD4-dependent citrullination of nuclear translocation of GSK3β promotes colorectal cancer progression via the degradation of nuclear CDKN1A.
Luo X; Chang S; Xiao S; Peng Y; Gao Y; Hu F; Liang J; Xu Y; Du K; Chen Y; Qin J; Meltzer SJ; Deng S; Feng X; Fan X; Hou G; Jin Z; Zhang X
Neoplasia; 2022 Nov; 33():100835. PubMed ID: 36113195
[TBL] [Abstract][Full Text] [Related]
19. Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors.
Chang X; Han J
Mol Carcinog; 2006 Mar; 45(3):183-96. PubMed ID: 16355400
[TBL] [Abstract][Full Text] [Related]
20. Investigating the cell membrane localization of PADI4 in breast cancer cells and inhibition of anti-PADI4 monoclonal antibody.
Wang Y; Song X; Song Y; Fang K; Chang X
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17253-17268. PubMed ID: 37804426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
